Security Snapshot

STANDARD BIOTOOLS INC. - Common Stock, $0.001 par value per share (LAB) Institutional Ownership

CUSIP: 34385P108

13F Institutional Holders and Ownership History from Q1 2014 to Q1 2026

Latest Period

Q4 2025

Institutions Reporting

159

Shares (Excl. Options)

302,674,845

Price

$1.28

Save this security page for your next review

Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.

Create free account and return here Sign in and return here Review latest holder period
Type / Class
Equity / Common Stock, $0.001 par value per share
Symbol
LAB on Nasdaq
Shares outstanding
384,731,503
Price per share
$0.89
All holders as of 31 Dec 2025
Q4 2025
Total 13F shares
302,674,845
Total reported value
$387,376,385
% of total 13F portfolios
0%
Share change
+16,914,793
Value change
+$21,629,884
Number of holders
159
Price from insider filings
$0.89
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Quick Takeaways

  • LAB - STANDARD BIOTOOLS INC. - Common Stock, $0.001 par value per share is tracked under CUSIP 34385P108.
  • 159 institutions reported positions in Q4 2025.
  • 2 significant owners is listed from Schedule 13D/13G reporting.

What Changed

  • Holder count moved from 159 to 54 between Q4 2025 and Q1 2026.
  • Reported value moved from $387,376,385 to $23,428,861.

Why This Matters

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Source Evidence

Source: SEC Form 13F

Latest holder context comes from 159 institutions filings for Q4 2025.

Open SEC Evidence

Investment Quick Answers

What is CUSIP 34385P108?
CUSIP 34385P108 identifies LAB - STANDARD BIOTOOLS INC. - Common Stock, $0.001 par value per share in SEC 13F datasets.

Where can I see the latest institutional holders?
Review the Q4 2025 holders report and the ownership history table below.

Significant Owners of STANDARD BIOTOOLS INC. - Common Stock, $0.001 par value per share (LAB) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Casdin Capital, LLC 24% +12% $107,459,205 +$14,465,243 93,442,787 +16% Eli Casdin 25 Nov 2025
MAK Capital Fund LP 5.2% $25,564,473 19,967,565 MAK Capital Fund LP 31 Dec 2025

As of 31 Dec 2025, 159 institutional investors reported holding 302,674,845 shares of STANDARD BIOTOOLS INC. - Common Stock, $0.001 par value per share (LAB). This represents 79% of the company’s total 384,731,503 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of STANDARD BIOTOOLS INC. - Common Stock, $0.001 par value per share (LAB) together control 75% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
Casdin Capital, LLC 23% 88,783,856 +14% 7.1% $113,643,336
VIKING GLOBAL INVESTORS LP 15% 58,651,170 0% 0.2% $75,073,498
BlackRock, Inc. 6.6% 25,515,933 +2.4% 0% $32,660,394
MAK CAPITAL ONE LLC 5% 19,288,158 +21% 3.3% $24,688,842
VANGUARD GROUP INC 4.5% 17,297,599 +0.3% 0% $22,140,926
Long Focus Capital Management, LLC 3.3% 12,678,403 +12% 0.82% $16,228,356
MORGAN STANLEY 2% 7,695,677 +21% 0% $9,850,466
GEODE CAPITAL MANAGEMENT, LLC 1.9% 7,420,696 -0.65% 0% $9,500,451
STATE STREET CORP 1.7% 6,482,766 +1.3% 0% $8,297,940
Hollow Brook Wealth Management LLC 1.4% 5,553,381 -3.8% 1.8% $7,108,328
NEUBERGER BERMAN GROUP LLC 1.2% 4,624,465 -2.1% 0% $5,912,342
Sumitomo Mitsui Trust Group, Inc. 1.1% 4,335,887 -20% 0% $5,549,935
Amova Asset Management Americas, Inc. 1.1% 4,335,887 -20% 0.06% $5,506,576
Tikvah Management LLC 0.92% 3,551,152 0% 1.2% $4,545,475
MILLENNIUM MANAGEMENT LLC 0.88% 3,387,428 +133% 0% $4,335,908
BARCLAYS PLC 0.8% 3,080,579 -3% 0% $3,943,141
ARK Investment Management LLC 0.8% 3,066,665 +1.5% 0.03% $3,925,331
ROYCE & ASSOCIATES LP 0.75% 2,885,529 +2.9% 0.04% $3,693,477
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 0.65% 2,508,064 +0.16% 0% $3,210,322
NORTHERN TRUST CORP 0.62% 2,390,544 -7.8% 0% $3,059,896
Nan Fung Group Holdings Ltd 0.49% 1,883,179 0% 2.2% $2,410,469
Slate Path Capital LP 0.42% 1,615,000 0% 0.03% $2,067,200
CITADEL ADVISORS LLC 0.28% 1,076,361 +120% 0% $1,377,742
Bank of New York Mellon Corp 0.21% 793,599 -0.57% 0% $1,015,807
JANE STREET GROUP, LLC 0.2% 769,231 +96% 0% $984,616

Institutional Holders of STANDARD BIOTOOLS INC. - Common Stock, $0.001 par value per share (LAB) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2026 Q1 25,494,714 $23,428,861 -$5,255,363 $0.92 54
2025 Q4 302,674,845 $387,376,385 +$21,629,884 $1.28 159
2025 Q3 285,807,620 $371,539,603 +$7,178,902 $1.30 154
2025 Q2 280,617,967 $336,678,756 -$1,077,649 $1.20 160
2025 Q1 281,593,693 $304,150,404 +$2,261,591 $1.08 146
2024 Q4 278,358,696 $487,066,151 -$5,656,598 $1.75 142
2024 Q3 281,191,207 $542,598,457 +$19,046,404 $1.93 141
2024 Q2 271,250,577 $480,012,531 -$2,577,119 $1.77 142
2024 Q1 265,331,245 $719,039,050 +$591,982,233 $2.71 144
2023 Q4 48,586,557 $107,409,627 +$2,035,800 $2.21 85
2023 Q3 47,429,426 $137,541,583 +$3,894,497 $2.90 72
2023 Q2 46,157,930 $89,085,103 +$111,792 $1.93 65
2023 Q1 46,097,170 $89,907,739 -$81,853 $1.95 68
2022 Q4 46,484,322 $54,406,276 -$819,975 $1.17 64
2022 Q3 38,636,548 $42,509,290 -$7,842,523 $1.10 59
2022 Q2 43,847,181 $70,155,656 -$17,366,200 $1.60 78
2022 Q1 49,928,925 $179,403,697 -$25,702,881 $3.59 103
2021 Q4 56,282,734 $220,394,393 -$14,652,768 $3.92 116
2021 Q3 58,458,125 $385,676,880 +$6,106,049 $6.59 116
2021 Q2 57,580,036 $354,421,486 -$3,050,736 $6.16 111
2021 Q1 59,027,044 $266,772,403 -$44,846,104 $4.52 131
2020 Q4 65,301,638 $391,716,950 -$13,720,267 $6.00 143
2020 Q3 65,965,282 $490,378,526 +$31,961,867 $7.43 131
2020 Q2 62,199,691 $249,441,661 -$3,129,865 $4.01 109
2020 Q1 64,133,221 $162,874,520 -$2,025,145 $2.54 101
2019 Q4 64,001,413 $222,706,158 -$9,721,596 $3.48 97
2019 Q3 63,874,892 $295,826,385 -$69,618,988 $4.63 123
2019 Q2 70,171,968 $864,468,233 +$79,902,351 $12.32 132
2019 Q1 64,290,483 $854,388,750 +$81,402,298 $13.29 131
2018 Q4 49,428,619 $426,070,543 +$92,525,147 $8.62 98
2018 Q3 38,859,260 $291,060,176 +$6,429,245 $7.49 79
2018 Q2 38,051,469 $226,778,750 +$6,133,731 $5.96 83
2018 Q1 37,033,370 $216,300,895 +$1,844,056 $5.84 80
2017 Q4 36,719,372 $217,359,750 +$4,377,610 $5.89 79
2017 Q3 36,202,469 $182,460,122 +$50,176,034 $5.04 77
2017 Q2 26,292,789 $106,212,221 -$4,700,293 $4.04 76
2017 Q1 27,134,410 $154,387,592 +$9,951,922 $5.69 78
2016 Q4 26,899,693 $195,651,510 -$9,634,235 $7.28 80
2016 Q3 27,197,265 $217,785,922 -$2,947,507 $8.01 91
2016 Q2 27,258,899 $246,146,890 -$13,971,192 $9.03 93
2016 Q1 28,544,853 $230,427,557 -$6,987,254 $8.07 95
2015 Q4 28,331,449 $306,249,733 -$18,748,499 $10.81 101
2015 Q3 31,054,676 $251,838,548 -$43,450,033 $8.11 101
2015 Q2 30,992,622 $749,720,524 -$49,296,665 $24.20 105
2015 Q1 30,648,463 $1,288,987,148 +$16,990,892 $42.10 103
2014 Q4 30,375,951 $1,024,527,502 +$65,370,838 $33.73 100
2014 Q3 28,669,722 $702,404,693 +$40,789,532 $24.50 98
2014 Q2 26,798,422 $787,833,600 -$670,493 $29.40 104
2014 Q1 26,208,819 $1,153,738,282 +$79,524,977 $44.07 106
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .